Role of transcriptional corepressor CtBP1 in prostate cancer progression
about
Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor designThe miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression.miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expressionSystematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancerCancer subclonal genetic architecture as a key to personalized medicine.MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer.Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.PBOV1 promotes prostate cancer proliferation by promoting G1/S transition.The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer.Silencing of CtBP1 suppresses the migration in human glioma cells.Hierarchical Feature Selection Incorporating Known and Novel Biological Information: Identifying Genomic Features Related to Prostate Cancer Recurrence.Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.Structure-guided design of a high affinity inhibitor to human CtBP.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationCTCF promotes epithelial ovarian cancer metastasis by broadly controlling the expression of metastasis-associated genes.Reconstructing cancer drug response networks using multitask learning.Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.Assembly of human C-terminal Binding Protein (CtBP) into tetramers.Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer ProgressionAn intestinal stem cell niche in mutated neoplasia targetable by CtBP inhibitionMicroRNA485-3p negatively regulates the transcriptional co-repressor to control the oncogenic process in osteosarcoma cells
P2860
Q27682367-B6C1C596-1F10-445B-9F37-AFF7882B0F1DQ34334347-8F313904-40D5-4EC1-8F8C-6C0EDE6BB3D3Q34769289-C585794F-C4AB-4DA9-B33F-98DFDB15FBEFQ35493037-678DD940-B857-4939-9B44-336E195ADFA2Q35742473-1CF3871D-61E6-4506-80AD-09D1BBD25D2EQ36545434-4E66DD44-0FA6-4C43-B501-691C65B3A03BQ37448116-F9714D55-C494-47AA-966B-47AD0DCFDCBDQ37478622-AAF00D80-E50C-4BC1-8597-759FCD54DA3AQ37555457-341EF3B1-1D62-4E3F-BA54-4D5E1E4DE063Q37629548-00605215-B6BD-4EA2-96A0-F8828E72A2E7Q38586921-92E8C5BB-9538-4706-B9A1-03C4F54CDC28Q38675402-673186D1-EE42-46E7-A49A-C0F9D7C2B531Q38680645-F3311B12-7CE1-4663-B7AE-7327876BCB8BQ38750703-E0CDDE57-F137-4EE0-8428-AE6A97618ECDQ38772235-83FEBE8F-2F4A-4659-8F55-894620793FB1Q38824071-32962093-99CA-4CF9-A6CA-6D5266DE52C4Q39156237-C37DC0B5-A802-40E9-BA4B-97BDC0B0D83DQ40601065-7A3C9ABA-0896-4942-9D4C-80794F2ADA27Q41879186-63B74E5E-30B9-467A-9BCB-5411C4F2BAB6Q41924394-A6FF069D-F455-4193-9584-DCAE848C0AE6Q42374512-38AA3E06-3DB1-4D31-AB6B-FCDA641F0DAEQ42382006-F8D6814F-60ED-4A53-BF5F-9E97748A7220Q46230467-2D5C3103-DE91-4D5C-BE6E-E9498E43B9B2Q47660322-35FBCC78-F3C3-4519-A195-0F83D44352CAQ52560313-91651437-ABEA-47D0-8E3F-D4EFA592CFB6Q55716532-4B147843-D0DE-452E-939A-0D357E70EBA4Q56334243-5D6E4CBF-FE6A-41D7-88A9-6DB4556682A8Q58727454-2C76467B-17EA-4C83-924E-423A01A96715Q58798244-6A6DB05B-1A83-4759-97BC-A7E712AD19CB
P2860
Role of transcriptional corepressor CtBP1 in prostate cancer progression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Role of transcriptional corepressor CtBP1 in prostate cancer progression
@ast
Role of transcriptional corepressor CtBP1 in prostate cancer progression
@en
type
label
Role of transcriptional corepressor CtBP1 in prostate cancer progression
@ast
Role of transcriptional corepressor CtBP1 in prostate cancer progression
@en
prefLabel
Role of transcriptional corepressor CtBP1 in prostate cancer progression
@ast
Role of transcriptional corepressor CtBP1 in prostate cancer progression
@en
P2093
P2860
P50
P356
P1433
P1476
Role of transcriptional corepressor CtBP1 in prostate cancer progression
@en
P2093
Arie P Otte
Arul M Chinnaiyan
Balabhadrapatruni V S K Chakravarthi
Heng Zheng
Javed Siddiqui
Lakshmi P Kunju
Mukesh K Nyati
Natalie McGregor
Radhika Menawat
Ram-Shankar Mani
P2860
P304
P356
10.1593/NEO.121192
P50
P577
2012-10-01T00:00:00Z